| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/04/2011 | CN101549023B Chinese medicine powder for treating beriberi |
| 05/04/2011 | CN101507789B Xiao Bi Tang decoction capable of treating psoriasis and preparation method thereof |
| 05/04/2011 | CN101507771B Burn scald rehabilitation medicine |
| 05/04/2011 | CN101461897B External use medicine for treating psoriasis |
| 05/04/2011 | CN101461864B Oral medicament composition for treating ordinary type ichthyosis |
| 05/04/2011 | CN101422554B Traditional Chinese medicine for treating acne |
| 05/04/2011 | CN101284031B Hairy holly root extract, its preparation and application |
| 05/04/2011 | CN101272786B Lotion preparation containing pyridonecarboxylic acid derivative |
| 05/04/2011 | CN101270110B Novel sulfonyl substituted benzophenone oxide compounds, prepraring method and application thereof |
| 05/04/2011 | CN101269171B Traditional Chinese medicine composition for treating dermatosis, preparation method and uses thereof |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/04/2011 | CN101204420B Infusum for snake bited ulcer |
| 05/04/2011 | CN101194973B Infusion medicament for treating impetigo |
| 05/04/2011 | CN101073575B Capsule for treating acne |
| 05/04/2011 | CN101014580B Morpholine compound |
| 05/03/2011 | US7935825 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 05/03/2011 | US7935692 Polyamine compounds are used to mobilize and harvest CD34+ cells via apheresis with and without combinations with other mobilizing factors; bind to chemokine receptors; regeneration of heart tissue |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935672 Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same |
| 05/03/2011 | US7935343 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 05/03/2011 | CA2684258A1 Compositions comprising plant extracts and methods of treating wounds, burns and skin injuries therewith |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2476343C 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors |
| 05/03/2011 | CA2473026C 2-(pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones |
| 05/03/2011 | CA2467517C Substituted benzoxazoles and analogues as estrogenic agents |
| 05/03/2011 | CA2443632C Timed pulse release composition |
| 05/03/2011 | CA2440438C Heterocyclic compounds |
| 05/03/2011 | CA2425933C Combination of catechin and quercetin for pharmaceutical or dietary use |
| 04/28/2011 | WO2011050311A1 Use of endostatin peptides for the treatment of fibrosis |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050099A2 Therapeutic composition |
| 04/28/2011 | WO2011050030A1 Alpha adrenergic receptor modulators |
| 04/28/2011 | WO2011049200A1 Antipruritic agent |
| 04/28/2011 | WO2011049093A1 Film-coated tablet which is suppressed in discoloration and odor |
| 04/28/2011 | WO2011049053A1 Intestinal mucosa-inherent myeloid cells inhibiting t cell activation and utilization of same |
| 04/28/2011 | WO2011048936A1 Aminothiazole derivative |
| 04/28/2011 | WO2011048554A2 Combination of a probiotic lysate and a c-glycoside derivative |
| 04/28/2011 | WO2011048496A1 Triptans for the treatment of psoriasis |
| 04/28/2011 | WO2011048409A1 Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/28/2011 | WO2011048350A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | WO2011048111A1 Compounds |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011047422A1 Anti-acne composition and use thereof |
| 04/28/2011 | WO2011047421A1 Antifungal composition and method of treatment of dermatitis |
| 04/28/2011 | WO2011047420A1 Cosmetic compositions |
| 04/28/2011 | WO2011028567A3 Composition and method for skin repair |
| 04/28/2011 | WO2010138770A3 Methods for administration and formulations for the treatment of regional adipose tissue |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | WO2008155659A3 Compositions for preventing or treating skin defects and methods of use thereof |
| 04/28/2011 | US20110098468 Nk1 antagonists |
| 04/28/2011 | US20110098467 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/28/2011 | US20110098350 Substituted cyclohexylidene-ethylidene-octahydro-indene compounds |
| 04/28/2011 | US20110098325 Pyridine benzamides and pyrazine benzamides used as pkd inhibitors |
| 04/28/2011 | US20110098319 Fatty acid derivatives for oral administration endowed with high palatability |
| 04/28/2011 | US20110098310 Novel compounds, use and preparation thereof |
| 04/28/2011 | US20110098308 Azaindazole compounds and methods of use |
| 04/28/2011 | US20110098302 Cyclic diaryl ether compounds as antagonists of prostaglandin d2 receptors |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098267 Topical formulations for the treatment of psoriasis |
| 04/28/2011 | US20110098256 Method for making and using a topical dermatological solution |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098246 Method for preventing corticosteroid usage |
| 04/28/2011 | US20110098229 Compositions and methods for treating dermatological conditions |
| 04/28/2011 | US20110098223 Use of the pat nanopeptide in the treatment of autoimmune diseases |
| 04/28/2011 | US20110097424 Herbal formulations for the management of chronic ulcers and wounds |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097391 Phospholipid Emulsion Containing Dihydroquercetin, and Method of Producing Thereof |
| 04/28/2011 | US20110097383 Apparatus and methods for enzymatic escharotomy in burn induced compartment syndrome |
| 04/28/2011 | US20110097381 Conformable tissue repair implant capable of injection delivery |
| 04/28/2011 | US20110097378 Decellularized liver for repair of tissue and treatment of organ deficiency |
| 04/28/2011 | US20110097372 Devices, methods, and compositions for controlling infections |
| 04/28/2011 | US20110097356 Anti-inflammatory and antioxidant cosmetic composition containing green tea polysaccharide and tricholoma matsutake extract |
| 04/28/2011 | US20110097344 Compositions, Methods for Treatment, and Diagnoses of Autoimmunity-Related Disorders and Methods for Making Such Compositions |
| 04/28/2011 | US20110097331 Antibodies that bind both il-17a and il-17f and methods of using the same |
| 04/28/2011 | US20110097325 Modulation of T cell Differentiation for the treatment of T helper cell mediated diseases |
| 04/28/2011 | US20110097310 Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng |
| 04/28/2011 | US20110097300 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 04/28/2011 | US20110097286 Compositions and methods for inhibiting par2 activation of keratinocytes |
| 04/28/2011 | US20110097281 Foam skin care cream |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | US20110097279 Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses |
| 04/28/2011 | DE102006041486B4 Kosmetische und dermatologische Zubereitung Cosmetic and dermatological preparation |
| 04/28/2011 | CA2815437A1 Triptans for the treatment of psoriasis |
| 04/28/2011 | CA2781522A1 Treatment using reprogrammed mature adult cells |
| 04/28/2011 | CA2778423A1 Alpha adrenergic receptor modulators |
| 04/28/2011 | CA2778350A1 Therapeutic composition |
| 04/28/2011 | CA2777902A1 Compounds |
| 04/28/2011 | CA2777489A1 Method for wetting a powder containing benzoyl peroxide |
| 04/27/2011 | EP2314673A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 04/27/2011 | EP2314624A2 Human antibody molecules for IL-13 |
| 04/27/2011 | EP2314601A1 Anti-inflammatory compounds and uses thereof |
| 04/27/2011 | EP2314321A1 Formulations comprising antisense nucleotides to connexins |
| 04/27/2011 | EP2314315A1 A blocking monoclonal antibody to the human alpha1 I-domain of VLA-1, and its use for the treatment of inflammatory disorders |
| 04/27/2011 | EP2313783A2 Pacap signaling pathway modulators for treating inflammatory skin diseases with a neurogenic component, and more particularly rosacea and composition containing them |
| 04/27/2011 | EP2313369A2 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 04/27/2011 | EP2313368A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 04/27/2011 | EP2313367A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 04/27/2011 | EP1303541B1 Compositions containing metronidazole |
| 04/27/2011 | EP1253966B1 Substances and agents for positively influencing collagen |
| 04/27/2011 | EP0934307B1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |